Real-world data from early access and patient access programs of avelumab first-line maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma in Australia

被引:0
作者
Moujaber, Tania
Tran Ben
Liow, Elizabeth
Clay, Timothy
Bennett, Geer
Kearney, Mairead
Gibberd, Alison
Gurney, Howard
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
abs68
引用
收藏
页码:94 / 95
页数:2
相关论文
共 50 条
[21]   Avelumab First-Line Maintenance Therapy: Managing Patients With Advanced Urothelial Carcinoma [J].
Lapuente, Maria ;
Conway, Dawn ;
Wood, Laura S. ;
Kehoe, Kiran ;
Bullock, Andrea Carroll ;
Devgan, Geeta ;
Burns, Kathleen D. .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (01) :71-80
[22]   Subgroup analyses from READY: Real-world data from an Italian compassionate use program (CUP) of avelumab first-line maintenance (1LM) treatment for locally advanced or metastatic urothelial carcinoma (la/mUC) [J].
Bracarda, Sergio ;
Antonuzzo, Lorenzo ;
Maruzzo, Marco ;
Santini, Daniele ;
Tambaro, Rosa ;
Buti, Sebastiano ;
Carrozza, Francesco ;
Calabro, Fabio ;
Di Lorenzo, Giuseppe ;
Fornarini, Giuseppe ;
Iacovelli, Roberto ;
Cullura, Daniela ;
Messina, Carlo ;
Cerbone, Linda ;
Fazzi, Gennaro ;
Venturini, Filippo ;
Colasanto, Raffaele ;
Necchi, Andrea ;
De Giorgi, Ugo .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) :558-558
[23]   Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study [J].
Miyake, Makito ;
Shimizu, Takuto ;
Oda, Yuki ;
Tachibana, Akira ;
Ohmori, Chihiro ;
Itami, Yoshitaka ;
Kiba, Keisuke ;
Tomioka, Atsushi ;
Yamamoto, Hiroaki ;
Ohnishi, Kenta ;
Nishimura, Nobutaka ;
Hori, Shunta ;
Morizawa, Yosuke ;
Gotoh, Daisuke ;
Nakai, Yasushi ;
Torimoto, Kazumasa ;
Fujii, Tomomi ;
Tanaka, Nobumichi ;
Fujimoto, Kiyohide .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (03) :253-262
[24]   Avelumab first-line (1L) maintenance treatment in patients with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Czech Republic: Updated real-world results from a national reimbursement registry. [J].
Studentova, Hana ;
Zemankova, Anezka ;
Melichar, Bohuslav ;
Eid, Michal ;
Poprach, Alexandr ;
Kopecky, Jindrich ;
Buchler, Tomas ;
Sustrova, Darja ;
Stuhlova, Sarka ;
Dvorak, Jan ;
Donatova, Zuzana ;
Vlcek, Pavel ;
Zychackova, Katerina ;
Katolicka, Jana ;
Blazek, Tomas ;
Vrana, David ;
Fiala, Ondrej ;
Majkova, Petra ;
Cepa, Adam .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL) :693-693
[25]   Preliminary results from AVENANCE, an ongoing, noninterventional real-world, ambispective study of avelumab first-line (1L) maintenance treatment in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) [J].
Barthelemy, P. ;
Thibault, C. ;
Voog, E. ;
Eymard, J-C. ;
Ravaud, A. ;
Flechon, A. ;
Jaillon, C. Abraham ;
Hilgers, W. ;
Le Moulec, S. ;
Chasseray, M. ;
Pouessel, D. ;
Amela, Y. E. ;
Lorgis, V. ;
Nicolas, E. ;
Kazan, E. ;
Denechere, G. ;
Solbes, M-N. ;
Lambert, P. ;
Loriot, Y. .
ANNALS OF ONCOLOGY, 2022, 33 (07) :S1341-S1342
[26]   Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC). [J].
Barthelemy, Philippe ;
Loriot, Yohann ;
Voog, Eric ;
Eymard, Jean Christophe ;
Ravaud, Alain ;
Flechon, Aude ;
Jaillon, Christine Abraham ;
Chasseray, Matthieu ;
Lorgis, Veronique ;
Hilgers, Werner ;
Gobert, AurElien ;
Le Moulec, Sylvestre ;
Simon, Camille ;
Nicolas, Emanuel ;
Escande, Anne ;
Pouessel, Damien ;
Josse, Constant ;
Solbes, Marie-Noelle ;
Lambert, Prisca ;
Thibault, Constance .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[27]   Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility [J].
Morgans, Alicia K. ;
Galsky, Matthew D. ;
Wright, Phoebe ;
Hepp, Zsolt ;
Chang, Nancy ;
Willmon, Candice L. ;
Sesterhenn, Steve ;
Liu, Yutong ;
Sonpavde, Guru P. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (08) :357e11-357e21
[28]   Real-world effectiveness and safety of avelumab first-line maintenance (1LM) treatment in patients with locally advanced or metastatic urothelial carcinoma (la/mUC): Second interim analysis of the AVENUE study. [J].
Goebell, Peter J. ;
Sultanbaev, Alexander Valerievich ;
Brachtel, Anna Leena ;
Molina, Aurea ;
Lorente, David ;
Zihler, Deborah ;
Wang, Lusha ;
Kostkova, Lenka ;
Hoffman, Jason ;
Cremer, Laura ;
Gschwend, Juergen E. .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
[29]   Real-world (rw) treatment patterns, sequencing, and outcomes in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) receiving avelumab first-line maintenance (1LM) in the US. [J].
Moon, Helen H. ;
Kearney, Mairead ;
Mahmoudpour, Seyed Hamidreza ;
Ike, Chiemeka ;
Morris, Valerie A. ;
Rava, Andrew ;
Kim, Sonia ;
Sun, Haiyan ;
Boyd, Marley ;
Rey, Gabriel Gomez .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) :605-605
[30]   Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice [J].
Grivas, Petros ;
Agarwal, Neeraj ;
Pal, Sumanta ;
Kalebasty, Arash Rezazadeh ;
Sridhar, Srikala S. ;
Smith, Jodi ;
Devgan, Geeta ;
Sternberg, Cora N. ;
Bellmunt, Joaquim .
CANCER TREATMENT REVIEWS, 2021, 97